How can a venture fund assist in drug development?20 August 2019 Primer Capital investment analyst Sofia Yartseva elaborated on the role of venture investments in drug development process and its further marketing.
Once the in vitro results on the efficacy of a drug are ready, comes the questions on pre-clinical and clinical trials. While the development costs increase exponentially along the process, in most cases, pharmaceutical companies are ready to support the project only after having passed the Phase II of the clinical trials. In order to overcome the so-called Valley of Death and introduce the product to the market private venture capital might be of great help. Read the full article here. (Note: the original copy is in Russian).
Back to the list